1. Home
  2. SLN vs TTSH Comparison

SLN vs TTSH Comparison

Compare SLN & TTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLN
  • TTSH
  • Stock Information
  • Founded
  • SLN 1994
  • TTSH 1985
  • Country
  • SLN United Kingdom
  • TTSH United States
  • Employees
  • SLN N/A
  • TTSH N/A
  • Industry
  • SLN Biotechnology: Pharmaceutical Preparations
  • TTSH Blank Checks
  • Sector
  • SLN Health Care
  • TTSH Finance
  • Exchange
  • SLN Nasdaq
  • TTSH Nasdaq
  • Market Cap
  • SLN 268.8M
  • TTSH 264.5M
  • IPO Year
  • SLN N/A
  • TTSH N/A
  • Fundamental
  • Price
  • SLN $4.73
  • TTSH $6.14
  • Analyst Decision
  • SLN Buy
  • TTSH
  • Analyst Count
  • SLN 5
  • TTSH 0
  • Target Price
  • SLN $32.60
  • TTSH N/A
  • AVG Volume (30 Days)
  • SLN 50.2K
  • TTSH 44.6K
  • Earning Date
  • SLN 11-13-2025
  • TTSH 11-06-2025
  • Dividend Yield
  • SLN N/A
  • TTSH N/A
  • EPS Growth
  • SLN N/A
  • TTSH N/A
  • EPS
  • SLN N/A
  • TTSH N/A
  • Revenue
  • SLN $27,169,000.00
  • TTSH $340,228,000.00
  • Revenue This Year
  • SLN N/A
  • TTSH N/A
  • Revenue Next Year
  • SLN N/A
  • TTSH N/A
  • P/E Ratio
  • SLN N/A
  • TTSH N/A
  • Revenue Growth
  • SLN 22.28
  • TTSH N/A
  • 52 Week Low
  • SLN $1.97
  • TTSH $4.62
  • 52 Week High
  • SLN $20.48
  • TTSH $7.75
  • Technical
  • Relative Strength Index (RSI)
  • SLN 41.23
  • TTSH 47.81
  • Support Level
  • SLN $4.77
  • TTSH $5.95
  • Resistance Level
  • SLN $5.80
  • TTSH $6.35
  • Average True Range (ATR)
  • SLN 0.36
  • TTSH 0.33
  • MACD
  • SLN -0.03
  • TTSH 0.00
  • Stochastic Oscillator
  • SLN 22.46
  • TTSH 30.84

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

Share on Social Networks: